Respiratory diseases

Asthma
Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Lui Z, Hartwell D, Loveman E, et al. Inhaled corticosteroids and Long Acting Beta-2 Agonists for the treatment of chronic asthma in children under the age of 12 years: Systematic review and economic analysis. Health Technology Assessment 2008;12(20).

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Lui Z, Loveman E, et al. Inhaled corticosteroids and Long Acting Beta-2 Agonists for the treatment of chronic asthma in adults and children aged 12 years and over: systematic review and economic analysis. Health Technology Assessment 2008;12(9).

Idiopathic pulmonary fibrosis

Loveman E, Copley V, Scott DA, Colquitt JL, Clegg AJ, O'Reilly K. Comparing new treatments for idiopathic pulmonary fibrosis: a network meta-analysis. BMC Pulmonary Medicine 2015: 15 (37)

Loveman E, Copley V, Colquitt JL, Scott D, Clegg A, Jones J, O'Reilly K, Singh S, Bausewein C, Wells A. The clinical and cost effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation. Health Technology Assessment 2015; 19(20)

Loveman E, Copley VR, Colquitt JL, Scott DA, Clegg AJ, Jones J, O'Reilly KMA, et al. The effectiveness and cost-effectiveness of treatments for Idiopathic Pulmonary Fibrosis: systematic review, network meta-analysis and health economic evaluation. BMC Pharmacology and Toxicology 2014; 15 (63).

 

Back to main publications page

  • Scoping
  • Protocol
  • Literature searching
  • Eligibility screening
  • Data extraction and critical appraisal
  • Data synthesis
  • Conclusions and recommendations